Invion Limited [ASX:IVX] share price and news 2022

Company Description

Invion Limited (IVX) is involved in the development of the Photosoft technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand license and distribution rights to the Photosoft technology. Research and clinical trials are funded by the technology licensor, RMW Cho Group, via an R&D services agreement with the Company.

Invion Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.inviongroup.com.

This a small cap company with market cap of 49 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 9 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how ivx dividend grows in the recent years.

No data